AI-generated from publicly available materials.ParkourSC has announced its acquisition of Quartic, aiming to create a comprehensive AI platform that integrates clinical and commercial supply chain capabilities with advanced manufacturing technology tailored for the life sciences sector.
This strategic acquisition is set to enhance visibility for pharmaceutical, biotechnology, and contract manufacturing organizations throughout the product lifecycle—from clinical development to distribution and point of care. The unified platform will facilitate the identification of quality risks earlier in the process, allowing organizations to take proactive measures to mitigate potential issues before they escalate.
The newly developed system will predict risks associated with specific batches and shipments, offering actionable recommendations such as adjusting manufacturing processes or prioritizing inventory. By consolidating various operational aspects—like deviation monitoring and regulatory documentation—into a single environment, the platform aims to streamline compliance and operational efficiency.
ParkourSC anticipates that this integration will not only double its market reach but also enhance the utilization of manufacturing evidence throughout the product lifecycle. This approach is expected to expedite transitions from clinical to commercial production, ultimately supporting faster decision-making in quality assurance and product release. With shared customers already benefiting from documented improvements, the partnership positions ParkourSC as a leader in advancing AI-driven supply chain solutions in the life sciences field.